Hsueh‐Ping Chao

1.7k total citations
19 papers, 1.1k citations indexed

About

Hsueh‐Ping Chao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hsueh‐Ping Chao has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hsueh‐Ping Chao's work include Prostate Cancer Treatment and Research (6 papers), Cancer Cells and Metastasis (5 papers) and Andrographolide Research and Applications (2 papers). Hsueh‐Ping Chao is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer Cells and Metastasis (5 papers) and Andrographolide Research and Applications (2 papers). Hsueh‐Ping Chao collaborates with scholars based in United States, China and Taiwan. Hsueh‐Ping Chao's co-authors include Dean G. Tang, Collene Jeter, Dingxiao Zhang, Jianjun Shen, Tao Yang, Yue Lu, Kiera Rycaj, Junchen Wang, Yi Zhong and Yoko Takata and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hsueh‐Ping Chao

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsueh‐Ping Chao United States 16 705 384 337 284 113 19 1.1k
Jia‐Jie Hao China 22 919 1.3× 358 0.9× 459 1.4× 284 1.0× 118 1.0× 58 1.4k
Rongfang Qiu China 21 732 1.0× 150 0.4× 269 0.8× 205 0.7× 198 1.8× 41 1.1k
Xianhui Ruan China 16 647 0.9× 262 0.7× 332 1.0× 138 0.5× 101 0.9× 63 982
Toshifumi Yae Japan 9 681 1.0× 339 0.9× 328 1.0× 135 0.5× 68 0.6× 18 1.0k
Min-Wei Chen Taiwan 13 788 1.1× 195 0.5× 257 0.8× 82 0.3× 97 0.9× 14 977
Kaori Koga Japan 16 379 0.5× 264 0.7× 135 0.4× 184 0.6× 156 1.4× 54 807
Uta Kossatz-Boehlert Germany 14 951 1.3× 689 1.8× 333 1.0× 117 0.4× 139 1.2× 15 1.4k
Anjan K. Pradhan United States 20 425 0.6× 239 0.6× 206 0.6× 63 0.2× 178 1.6× 33 854
Yanhua Xuan China 18 539 0.8× 381 1.0× 221 0.7× 115 0.4× 111 1.0× 47 884

Countries citing papers authored by Hsueh‐Ping Chao

Since Specialization
Citations

This map shows the geographic impact of Hsueh‐Ping Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsueh‐Ping Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsueh‐Ping Chao more than expected).

Fields of papers citing papers by Hsueh‐Ping Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsueh‐Ping Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsueh‐Ping Chao. The network helps show where Hsueh‐Ping Chao may publish in the future.

Co-authorship network of co-authors of Hsueh‐Ping Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Hsueh‐Ping Chao. A scholar is included among the top collaborators of Hsueh‐Ping Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsueh‐Ping Chao. Hsueh‐Ping Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kowalski, Jeanne, et al.. (2022). KRAS mutation methylation clonality in early-stage pancreatic cancer.. Journal of Clinical Oncology. 40(4_suppl). 614–614. 1 indexed citations
2.
Zhang, Dingxiao, Qiang Hu, Xiaozhuo Liu, et al.. (2020). Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nature Communications. 11(1). 2089–2089. 88 indexed citations
3.
Chao, Hsueh‐Ping, Yueping Chen, Yoko Takata, et al.. (2019). Systematic evaluation of RNA-Seq preparation protocol performance. BMC Genomics. 20(1). 571–571. 27 indexed citations
5.
Koutelou, Evangelia, Li Wang, Andreas Schibler, et al.. (2019). USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta. Development. 146(4). 30 indexed citations
6.
Tomida, Junya, Kei‐ichi Takata, Maria D. Person, et al.. (2018). FAM 35A associates with REV 7 and modulates DNA  damage responses of normal and BRCA 1‐defective cells. The EMBO Journal. 37(12). 79 indexed citations
7.
Liu, Can, Ruifang Liu, Dingxiao Zhang, et al.. (2017). MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nature Communications. 8(1). 14270–14270. 186 indexed citations
8.
Chen, Xin, Qiuhui Li, Xin Liu, et al.. (2016). Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(17). 4505–4516. 75 indexed citations
9.
Jeter, Collene, Bigang Liu, Yue Lu, et al.. (2016). NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discovery. 2(1). 16041–16041. 42 indexed citations
10.
Zhang, Dingxiao, Daechan Park, Yi Zhong, et al.. (2016). Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nature Communications. 7(1). 10798–10798. 148 indexed citations
12.
Zhang, Dingxiao, Kevin Lin, Yue Lu, et al.. (2016). Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer. Stem Cells Translational Medicine. 6(3). 748–760. 18 indexed citations
13.
Liu, Xin, Xin Chen, Kiera Rycaj, et al.. (2015). Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 6(27). 23959–23986. 58 indexed citations
14.
Jeter, Collene, Tao Yang, Junchen Wang, Hsueh‐Ping Chao, & Dean G. Tang. (2015). Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells. 33(8). 2381–2390. 180 indexed citations
16.
Hsu, Kate, et al.. (2011). Expression of the Rh/RhAG complex is reduced in Mi.III erythrocytes. Vox Sanguinis. 102(3). 221–227. 7 indexed citations
17.
Chao, Hsueh‐Ping, Cheng‐Deng Kuo, Jen‐Hwey Chiu, & Shu‐Ling Fu. (2010). Andrographolide Exhibits Anti-Invasive Activity against Colon Cancer Cells via Inhibition of MMP2 Activity. Planta Medica. 76(16). 1827–1833. 40 indexed citations
18.
Lin, Chao, et al.. (2007). Suppression of v-Src Transformation by Andrographolide via Degradation of the v-Src Protein and Attenuation of the Erk Signaling Pathway. Journal of Biological Chemistry. 283(8). 5023–5033. 46 indexed citations
19.
Chao, Hsueh‐Ping, et al.. (1974). Selective uptake of specifically purified antibodies to carcinoembryonic antigen of human adenocarcinoma.. PubMed. 9(4). 749–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026